For more than 20 years, hormone therapy for menopause has carried a warning label from the Food and Drug Administration ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — CD19 chimeric antigen receptor T-cell therapy led to remission, or ceased disease progression, over ...
Many doctors agree with the Food and Drug Administration’s recent decision to remove the black box warnings on at least some forms of hormone therapy used to treat the symptoms of menopause. But in ...
The RECIST guidelines provide a standardized approach for evaluating the response of cancer to treatment, allowing for consistent comparison of treatment efficacy across different therapies and ...
All menopause treatments containing the hormone estrogen are mandated by the US Food and Drug Administration to carry a black box warning on the label, stating that the treatments could increase the ...
Serial metastasis-directed radiotherapy extended time off systemic therapy while maintaining favorable progression-free and overall survival in patients with oligometastatic clear-cell renal cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results